unani treatment for dark patches on face

Efficacy of Kutki Siyah with Roghan e Kunjad topically vs Tila e Muqil in Kalaf Melasma A Randomized comparative Clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104204

Enrollment

Registered

2026-02-18

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

Intervention1: Kutki siyah with roghan e Kunjad: All the drugs will be cleaned and authenticated. Required quantity of Kutki siyah (Kharbaq siyah) will be powdered and mixed with Roghan-e-kunjad. Dose

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed Patients of Epidermal Melasma (Kalaf) Mild to Moderate cases of Melasma Subjects who are willing to give consent

Exclusion criteria

Exclusion criteria: Severe cases of Melasma Pregnant and lactating women Individuals using oral contraceptive pills and hormonal intrauterine devices Subjects with skin sensitivity and Immunocompromised patients Other Hyper pigmentary conditions like post inflammatory hyperpigmentation Freckles Subjects who have received laser therapy chemical peeling or any other treatments for Melasma within the last 30 days.

Design outcomes

Primary

Measure	Time frame
Reduction in m-MASI Score Dermoscopic changes Timepoint: 10thDay 20thDay 30thDay 40thDay Dermoscopy on baseline and post treatment	—

Secondary

Measure	Time frame
Improvement in DLQI score.Timepoint: 10thDay 20thDay 30thDay 40thDay	—

Countries

India

Contacts

Public ContactProfessor Ayesha Tabasum

Government Unani Medical College and Hospital

ayesharafeeq81@yahoo.com9035158024

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026